Michael Yee

UBS | Healthcare

Michael Yee is an analyst from UBS specializing in the Healthcare sector. Ranked #1250 out of 4694 analysts, they have issued 49 stock ratings with a success rate of 85.61% and an average return of 17.96%.

Michael Yee has a well-established track record, with 49 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 85.61% and an average return of 17.96%, underscoring their expertise and ability to identify winning opportunities for investors.

#1250

Out of 4694

49

Total Ratings

+85.61%

Success Rate

+17.96%

Average Return

Recent Ratings Analysis

APGE

Jun 23, 2026

Target

$135.11

Current

$132.55

Performance

—

Michael Yee rated APGE as Neutral on Jun 23, 2026, setting a price target of 135.11. The Hold stance appears justified, as shares hovered around 132.55 with a % move.

JBIO

Jun 15, 2026

Target

$45.00

Current

$19.45

Performance

20.81%

On Jun 15, 2026, JBIO was given a Buy rating by Michael Yee, with a target price of 45. The stock rallied 20.81% after the rating, narrowing the gap to the target of 45 and validating the bullish stance.

ANAB

May 13, 2026

Target

$76.00

Current

$59.99

Performance

-4.31%

ANAB received a Buy rating from Michael Yee on May 13, 2026, aiming for 76. Price action was muted, as shares hovered around 59.99 despite the bullish outlook.

ORKA

Apr 28, 2026

Target

$100.00

Current

$85.38

Performance

15.39%

On Apr 28, 2026, Michael Yee published a Buy outlook on ORKA, with a target of 100. Shares gained 15.39%, underscoring the accuracy of the bullish outlook toward 100.

BIIB

Apr 22, 2026

Target

$225.00

Current

$199.71

Performance

5.07%

Michael Yee on Apr 22, 2026 assigned BIIB a Buy rating, with a price target of 225. The Buy call aligned well with market performance, producing a gain of 5.07%.

PFE

Apr 13, 2026

Target

$27.00

Current

$25.08

Performance

-8.27%

On Apr 13, 2026, Michael Yee reaffirmed PFE with a Neutral rating, targeting 27. The Hold stance reflected market caution that was later justified.

MRK

Apr 13, 2026

Target

$145.00

Current

$115.46

Performance

-3.90%

MRK was rated Buy by Michael Yee on Apr 13, 2026, with a price objective of 145. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

AMGN

Apr 13, 2026

Target

$400.00

Current

$344.72

Performance

-1.46%

On Apr 13, 2026, Michael Yee initiated coverage on AMGN with a Buy rating and target of 400. Neutral price movement of -1.46% leaves room for interpretation.

KOD

Mar 27, 2026

Target

$80.00

Current

$36.63

Performance

-1.00%

Michael Yee issued a Buy recommendation for KOD on Mar 27, 2026, price target set at 80. The target of 80 remains in play, though confirmation will depend on future moves.

SDGR

Mar 17, 2026

Target

$13.00

Current

$15.23

Performance

23.92%

On Mar 17, 2026, SDGR was evaluated by Michael Yee, who gave a Neutral rating and target of 13. Investors who stayed in despite the Hold saw upside of 23.92%.

NUVB

Mar 03, 2026

Target

$10.00

Current

$5.76

Performance

32.11%

Michael Yee rated NUVB as Neutral on Mar 03, 2026, setting a price target of 10. Despite the Hold call, shares climbed 32.11% to 5.76, revealing unexpected momentum.

ACLX

Feb 24, 2026

Target

$115.00

Current

$115.07

Performance

1.16%

On Feb 24, 2026, ACLX was given a Neutral rating by Michael Yee, with a target price of 115. Market indecision, reflected in sideways trading near 115.07, supported the cautious call.

GLTO

Feb 17, 2026

Target

$45.00

Current

$21.58

Performance

-27.85%

GLTO received a Buy rating from Michael Yee on Feb 17, 2026, aiming for 45. The rating hasn’t played out as hoped, with the stock trading 27.85% below expectations.

ABBV

Feb 05, 2026

Target

$230.00

Current

$230.06

Performance

5.04%

On Feb 05, 2026, Michael Yee published a Neutral outlook on ABBV, with a target of 230. The Hold call missed some of the bullish momentum as shares advanced toward 230.

GILD

Jan 26, 2026

Target

$155.00

Current

$124.87

Performance

-9.37%

Michael Yee on Jan 26, 2026 assigned GILD a Buy rating, with a price target of 155. The call has struggled to gain traction, with shares losing 9.37%.

VRTX

Jan 26, 2026

Target

$545.00

Current

$466.79

Performance

-2.11%

On Jan 26, 2026, Michael Yee reaffirmed VRTX with a Buy rating, targeting 545. Market indecision has kept the 545 target in a holding pattern.

VTYX

Jan 08, 2026

Target

$20.00

Current

$14.00

Performance

1.16%

VTYX was rated Neutral by Michael Yee on Jan 08, 2026, with a price objective of 20. Flat performance suggests the Hold view was reasonable.

IMCR

Jan 07, 2026

Target

$55.00

Current

$29.35

Performance

-13.06%

On Jan 07, 2026, Michael Yee initiated coverage on IMCR with a Buy rating and target of 55. The Buy call has yet to be validated as shares remain 25.65 away from the target.

BMY

Jan 07, 2026

Target

$65.00

Current

$54.70

Performance

-3.56%

Michael Yee issued a Buy recommendation for BMY on Jan 07, 2026, price target set at 65. The target of 65 remains in play, though confirmation will depend on future moves.

LLY

Jan 07, 2026

Target

$1250.00

Current

$1103.68

Performance

-0.40%

On Jan 07, 2026, LLY was evaluated by Michael Yee, who gave a Buy rating and target of 1250. So far, the Buy call awaits clearer momentum, with shares flat at 1103.68.

ALGS

Jan 07, 2026

Target

$20.00

Current

$5.69

Performance

-41.04%

Michael Yee rated ALGS as Buy on Jan 07, 2026, setting a price target of 20. The stock has underperformed, dropping 41.04% despite the bullish target of 20.

ALLO

Jan 07, 2026

Target

$8.00

Current

$2.10

Performance

40.94%

On Jan 07, 2026, ALLO was given a Buy rating by Michael Yee, with a target price of 8. The stock rallied 40.94% after the rating, narrowing the gap to the target of 8 and validating the bullish stance.

BEAM

Jan 07, 2026

Target

$28.00

Current

$35.53

Performance

22.81%

BEAM received a Neutral rating from Michael Yee on Jan 07, 2026, aiming for 28. Investors saw gains of 22.81% that the cautious stance didn’t fully capture.

MBX

Jan 07, 2026

Target

$60.00

Current

$43.91

Performance

34.90%

On Jan 07, 2026, Michael Yee published a Buy outlook on MBX, with a target of 60. Shares gained 34.90%, underscoring the accuracy of the bullish outlook toward 60.

OLMA

Jan 07, 2026

Target

$45.00

Current

$10.00

Performance

-63.06%

Michael Yee on Jan 07, 2026 assigned OLMA a Buy rating, with a price target of 45. The call has struggled to gain traction, with shares losing 63.06%.

SABS

Jan 07, 2026

Target

$7.00

Current

$3.93

Performance

-1.01%

On Jan 07, 2026, Michael Yee reaffirmed SABS with a Buy rating, targeting 7. Market indecision has kept the 7 target in a holding pattern.

SRRK

Jan 07, 2026

Target

$60.00

Current

$49.19

Performance

11.21%

SRRK was rated Buy by Michael Yee on Jan 07, 2026, with a price objective of 60. A bullish response from the market helped close the gap of 10.81 to the target.

VRDN

Jan 07, 2026

Target

$50.00

Current

$17.63

Performance

-42.33%

On Jan 07, 2026, Michael Yee initiated coverage on VRDN with a Buy rating and target of 50. The Buy call has yet to be validated as shares remain 32.37 away from the target.

ZLAB

Jan 07, 2026

Target

$35.00

Current

$18.48

Performance

-2.89%

Michael Yee issued a Buy recommendation for ZLAB on Jan 07, 2026, price target set at 35. The target of 35 remains in play, though confirmation will depend on future moves.

DNLI

Jan 07, 2026

Target

$25.00

Current

$24.05

Performance

41.89%

On Jan 07, 2026, DNLI was evaluated by Michael Yee, who gave a Buy rating and target of 25. This case illustrates how a timely bullish rating can translate into tangible gains of 41.89%.

IDYA

Jan 07, 2026

Target

$50.00

Current

$34.23

Performance

-9.59%

Michael Yee rated IDYA as Buy on Jan 07, 2026, setting a price target of 50. The stock has underperformed, dropping 9.59% despite the bullish target of 50.

IVA

Jan 07, 2026

Target

$12.00

Current

$3.51

Performance

-31.18%

On Jan 07, 2026, IVA was given a Buy rating by Michael Yee, with a target price of 12. Despite the Buy call, shares fell from 3.51 to 3.51, challenging the optimistic stance.

CRGX

Jul 08, 2025

Target

$5.00

Current

$4.47

Performance

-2.40%

CRGX received a Hold rating from Michael Yee on Jul 08, 2025, aiming for 5. Shares remained flat at 4.47, aligning with the neutral rating.

BPMC

Mar 17, 2025

Target

$135.00

Current

$129.46

Performance

40.50%

On Mar 17, 2025, Michael Yee published a Buy outlook on BPMC, with a target of 135. Shares gained 40.50%, underscoring the accuracy of the bullish outlook toward 135.

ALXO

Mar 06, 2025

Target

$3.00

Current

$1.63

Performance

24.43%

Michael Yee on Mar 06, 2025 assigned ALXO a Buy rating, with a price target of 3. The Buy call aligned well with market performance, producing a gain of 24.43%.

MRNA

Oct 15, 2024

Target

$55.00

Current

$59.34

Performance

3.55%

On Oct 15, 2024, Michael Yee reaffirmed MRNA with a Hold rating, targeting 55. The neutral call matched muted market action of 3.55%.

AXON

Jul 17, 2024

Target

$385.00

Current

$410.03

Performance

29.03%

AXON was rated Buy by Michael Yee on Jul 17, 2024, with a price objective of 385. A bullish response from the market helped close the gap of -25.03 to the target.

Frequency Asked Questions

Who is Michael Yee?

Michael Yee is an analyst from UBS specializing in the Healthcare sector.

What is Michael Yee's success rate?

Michael Yee currently has a success rate of +85.61%.

How many ratings has Michael Yee issued?

Michael Yee has issued 49 stock ratings so far.

What is the average return of Michael Yee's calls?

Their stock ratings have generated an average return of +17.96%.

What is Michael Yee's ranking?

Michael Yee is ranked #1250 out of 4694 analysts.

What types of ratings does Michael Yee give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Michael Yee?

You can follow Michael Yee by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Michael Yee?

Their latest rating was a Hold on APGE issued on 2026-06-23.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep